Samsung Bioepis to Present Post-hoc Analysis of Phase 3
Post-hoc analysis of Phase 3 study to highlight transfusion avoidance results of SB12 compared to reference eculizumab-treated groups INCHEON, Korea, May ...
Source: globenewswire.com
📰 Transfusion Avoidance News
Transfusion Avoidance News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Transfusion Avoidance. Real-time updates on events, politics, business and more.